Lebwohl David
CIK 0001810882
EVP, Chief Medical Officer
Filings
13
Latest Mar 3, 2026
Issuers covered
1
Showing
13 of 13
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 60% | +2.6% | +14.2% | +21.4% | -31.9% |
| 90 days | 5 | 80% | +11.9% | +14.9% | +43.2% | -41.9% |
| 180 days | 4 | 75% | +19.6% | +17.7% | +46.9% | -4.0% |
| 365 days | 4 | 100% | +44.2% | +41.6% | +70.9% | +22.8% |
Issuers
Companies where Lebwohl David has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | 13 | Mar 3, 2026 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|